Researchers identify biomarker for likely aggressive, early-stage breast cancers

[News]

The one-size-fits-all approach to early stage breast cancer creates a paradox: Millions of dollars are spent on unnecessary surgeries and radiation to treat women with low-risk 'in situ' lesions, an estimated 85% of which would never progress to invasive cancers.

More... (http://www.news-medical.net/news/20170404/Researchers-identify-biomarker-for-likely-aggressive-early-stage-breast-cancers.aspx)